Signs of Rhabdomyolysis
The classic triad of rhabdomyolysis consists of muscle pain, weakness, and dark (tea-colored) urine, though this complete triad is present in less than 10% of cases. 1
Clinical Symptoms
Muscle-Related Symptoms:
- Muscle pain, soreness, or aching is the most common presenting symptom, though it may be absent in severe cases 1
- Muscle weakness affecting large muscle groups, particularly the thighs, calves, and lower back 1
- Muscle stiffness and cramping can occur, especially in statin-associated cases 2
- Severe fatigue that is unexplained and disproportionate to activity level 2
Urinary Signs:
- Dark brown or tea-colored urine indicating myoglobinuria 2
- Urinalysis showing positive blood without red blood cells (myoglobin cross-reacts with hemoglobin on dipstick) 2
- Cloudy urine appearance 2
Early Warning Signs in High-Risk Contexts
In Compartment Syndrome (which can both cause and complicate rhabdomyolysis):
- Pain, tension, paresthesias, and paresis are early signs requiring immediate intervention 2
- Pulselessness and pallor are late signs indicating irreversible damage 2
Laboratory Findings
Essential Diagnostic Markers:
- Creatine kinase (CK) elevation >1,000 IU/L, with severe cases showing CK >15,000 IU/L 2
- Elevated serum myoglobin (though this clears rapidly from circulation) 2
- Hyperkalemia which can precipitate life-threatening cardiac arrhythmias 2
- Elevated creatinine indicating acute kidney injury 1
- Elevated AST, ALT, LDH, and aldolase due to muscle enzyme release 2
Special Considerations in Statin-Treated and Hypothyroid Patients
Statin-Associated Rhabdomyolysis:
- Symptoms may develop weeks to months after starting therapy, not just immediately 3
- Severe myositis with CK >10 times upper limit of normal is the hallmark of statin-induced rhabdomyolysis 1
- Risk is dramatically increased when statins are combined with fibrates (particularly gemfibrozil), macrolide antibiotics, antifungals, or cyclosporine 1, 4
Hypothyroidism as a Risk Factor:
- Undiagnosed hypothyroidism significantly increases the risk of statin-induced rhabdomyolysis 5, 6, 7
- Hypothyroidism itself can cause subclinical muscle injury that becomes clinically apparent when statins are added 5, 7
- Screen for hypothyroidism (TSH, free T4) in any patient developing muscle symptoms on statins 1
Critical Action Points
When to Act Immediately:
- Discontinue the statin immediately if unexplained severe muscle symptoms or fatigue develop 1
- Evaluate CK, creatinine, and urinalysis for myoglobinuria promptly 1
- Check serum potassium and obtain ECG to assess for life-threatening hyperkalemia 2
- Initiate aggressive fluid resuscitation early, as delayed treatment increases acute kidney injury risk 2
Common Pitfalls
- Do not wait for the classic triad - many patients present with only one or two symptoms 1
- CK levels peak 24-120 hours after the inciting event, so initial levels may not reflect the severity 2
- Muscle symptoms may be mild or absent even in severe rhabdomyolysis, particularly in elderly or debilitated patients 3
- Rhabdomyolysis can occur even after drug discontinuation, as symptoms may be delayed 3